Immuno-PET: Design options and clinical proof-of-concept

Radioimmunoconjugates have been used for over 30 years in nuclear medicine applications. In the last few years, advances in cancer biology knowledge have led to the identification of new molecular targets specific to certain patient subgroups. The use of these targets in targeted therapies approache...

Descripción completa

Detalles Bibliográficos
Autores principales: Lugat, Alexandre, Bailly, Clément, Chérel, Michel, Rousseau, Caroline, Kraeber-Bodéré, Françoise, Bodet-Milin, Caroline, Bourgeois, Mickaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613928/
https://www.ncbi.nlm.nih.gov/pubmed/36314010
http://dx.doi.org/10.3389/fmed.2022.1026083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613928/
https://www.ncbi.nlm.nih.gov/pubmed/36314010
http://dx.doi.org/10.3389/fmed.2022.1026083

Ejemplares similares